Immunotherapy partnership advances space medicine research
Drug Discovery World
JANUARY 25, 2024
US company Vaxxinity and the University of Central Florida (UCF) have announced plans to work together to advance space medicine research. The research, funded by a grant from the State of Florida, aims to develop Vaxxinity’s active immunotherapies to prevent and mitigate muscle and bone wasting.
Let's personalize your content